Barely Significant
← all excerpts

Targeting SCAMP2 by a natural product auxarconjugatin B for glioblastoma therapy <i>via</i> restoring aspartate metabolic flux.

Acta Pharm Sin B · 2026 · PMC13198271 · PMID 42180528

Europe PMCDOI
1
hedged sentence
—
closest p
—
boldest claim

The sentences

a decreasing trendno p-value reported
an increasing trendno p-value reported
As expected, the protein expressions of ASNS exhibited a decreasing trend in the SCAMP2 overexpressing group and an increasing trend in the SCAMP2 knockdown group, while the expression levels of the aspartate transporters SLC1A3 and SLC25A12 remained unchanged ( Fig. 5 C, Supporting Information Fig.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.